# The Effects of Inhalational Anaesthetics in Cognitive Functions in Down Syndrome Patients

> **NCT02971254** · PHASE2 · COMPLETED · sponsor: **Asklepieion Voulas General Hospital** · enrollment: 39 (actual)

## Conditions studied

- Down Syndrome

## Interventions

- **DRUG:** Sevoflurane
- **DRUG:** Desflurane

## Key facts

- **NCT ID:** NCT02971254
- **Lead sponsor:** Asklepieion Voulas General Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-01
- **Primary completion:** 2019-01-06
- **Final completion:** 2019-05-30
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2020-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02971254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02971254, "The Effects of Inhalational Anaesthetics in Cognitive Functions in Down Syndrome Patients". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT02971254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*